JP2025503034A5 - - Google Patents
Info
- Publication number
- JP2025503034A5 JP2025503034A5 JP2024543083A JP2024543083A JP2025503034A5 JP 2025503034 A5 JP2025503034 A5 JP 2025503034A5 JP 2024543083 A JP2024543083 A JP 2024543083A JP 2024543083 A JP2024543083 A JP 2024543083A JP 2025503034 A5 JP2025503034 A5 JP 2025503034A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- nucleotides
- rnai oligonucleotide
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263301454P | 2022-01-20 | 2022-01-20 | |
| US63/301,454 | 2022-01-20 | ||
| US202263328629P | 2022-04-07 | 2022-04-07 | |
| US63/328,629 | 2022-04-07 | ||
| PCT/US2023/011200 WO2023141247A2 (en) | 2022-01-20 | 2023-01-20 | Compositions and methods for inhibiting complement factor b |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503034A JP2025503034A (ja) | 2025-01-30 |
| JP2025503034A5 true JP2025503034A5 (enExample) | 2026-01-27 |
Family
ID=87349101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543083A Pending JP2025503034A (ja) | 2022-01-20 | 2023-01-20 | 補体因子ｂを阻害するための組成物及び方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20250327070A1 (enExample) |
| EP (1) | EP4465996A2 (enExample) |
| JP (1) | JP2025503034A (enExample) |
| KR (1) | KR20240135650A (enExample) |
| AU (1) | AU2023208539A1 (enExample) |
| CA (1) | CA3247136A1 (enExample) |
| CL (1) | CL2024002156A1 (enExample) |
| CO (1) | CO2024011199A2 (enExample) |
| CR (1) | CR20240346A (enExample) |
| DO (1) | DOP2024000140A (enExample) |
| IL (1) | IL314240A (enExample) |
| MX (1) | MX2024009019A (enExample) |
| PE (1) | PE20250156A1 (enExample) |
| TW (1) | TW202345866A (enExample) |
| UY (1) | UY40118A (enExample) |
| WO (1) | WO2023141247A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121532510A (zh) * | 2023-07-28 | 2026-02-13 | 苏州炫景生物科技有限公司 | Cfb抑制剂组合物及其应用 |
| WO2025113592A1 (zh) * | 2023-12-01 | 2025-06-05 | 厦门甘宝利生物医药有限公司 | 一种抑制补体系统基因表达的rna抑制剂及其应用 |
| WO2025140402A1 (zh) * | 2023-12-28 | 2025-07-03 | 苏州瑞博生物技术股份有限公司 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
| WO2025151250A2 (en) * | 2024-01-09 | 2025-07-17 | Adarx Pharmaceuticals, Inc. | Complement factor b-modulating compositions and methods of use thereof |
| US20250382616A1 (en) * | 2024-06-18 | 2025-12-18 | Sanegene Bio Usa Inc. | Small interfering rna targeting cfb and uses thereof |
| WO2026046277A1 (zh) * | 2024-08-28 | 2026-03-05 | 倍臻生物技术（苏州）有限公司 | 用于抑制补体因子b(cfb)基因表达的双链核糖核酸及其缀合体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201804960RA (en) * | 2013-12-12 | 2018-07-30 | Alnylam Pharmaceuticals Inc | Complement component irna compositions and methods of use thereof |
| JP2023523790A (ja) * | 2020-04-30 | 2023-06-07 | アルナイラム ファーマシューティカルズ， インコーポレイテッド | 補体因子Ｂ（ＣＦＢ）ｉＲＮＡ組成物およびその使用方法 |
-
2023
- 2023-01-19 UY UY0001040118A patent/UY40118A/es unknown
- 2023-01-19 TW TW112102833A patent/TW202345866A/zh unknown
- 2023-01-20 AU AU2023208539A patent/AU2023208539A1/en active Pending
- 2023-01-20 CR CR20240346A patent/CR20240346A/es unknown
- 2023-01-20 EP EP23743749.6A patent/EP4465996A2/en active Pending
- 2023-01-20 PE PE2024001648A patent/PE20250156A1/es unknown
- 2023-01-20 KR KR1020247027278A patent/KR20240135650A/ko active Pending
- 2023-01-20 JP JP2024543083A patent/JP2025503034A/ja active Pending
- 2023-01-20 IL IL314240A patent/IL314240A/en unknown
- 2023-01-20 US US18/292,187 patent/US20250327070A1/en active Pending
- 2023-01-20 WO PCT/US2023/011200 patent/WO2023141247A2/en not_active Ceased
- 2023-01-20 CA CA3247136A patent/CA3247136A1/en active Pending
-
2024
- 2024-07-18 CL CL2024002156A patent/CL2024002156A1/es unknown
- 2024-07-18 DO DO2024000140A patent/DOP2024000140A/es unknown
- 2024-07-19 MX MX2024009019A patent/MX2024009019A/es unknown
- 2024-09-05 CO CONC2024/0011199A patent/CO2024011199A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025503034A5 (enExample) | ||
| JP2023523790A5 (enExample) | ||
| JP2023536974A5 (enExample) | ||
| JP2024081668A5 (enExample) | ||
| JP2024037871A5 (enExample) | ||
| JP2024515344A5 (enExample) | ||
| JP2020072732A5 (enExample) | ||
| JP2023103244A5 (enExample) | ||
| JP6752151B2 (ja) | 遺伝子サイレンシングにおいて低下したｏｆｆ−ｔａｒｇｅｔ効果を有するｕｎａオリゴマー | |
| US20230203498A1 (en) | Single-stranded oligonucleotide | |
| JP2021006029A5 (enExample) | ||
| JP2023518409A5 (enExample) | ||
| JP2024541989A5 (enExample) | ||
| JP2019214587A5 (enExample) | ||
| JP2016533751A5 (enExample) | ||
| JP2020533334A5 (enExample) | ||
| JP2023530461A5 (enExample) | ||
| JP2024535888A5 (enExample) | ||
| JP2020529197A5 (enExample) | ||
| JP2019529489A5 (enExample) | ||
| JP2010539950A5 (enExample) | ||
| JP2024516356A5 (enExample) | ||
| JP2021515784A (ja) | 修飾オリゴヌクレオチド及びタウオパチーにおける使用方法 | |
| JP2022520986A5 (enExample) | ||
| JP2021511072A5 (enExample) |